All News

A major shift in expenditures by payer type for opioid pain relievers occurred along with a 4-fold increase in overdose deaths from opioids in the United States.

What we're reading, May 25, 2016: Senior citizens are expected to be sicker and more costly than the previous generation; men with early-stage cancer are increasingly choosing to avoid treatment; and the FDA is looking at an implantable treatment for opioid addiction.

Two months after the approval of the first biosimilar to infliximab, another Biologics License Application is now under FDA review.

The smallest overall increase in the MMI in 15 years is masked by the fact that employees are bearing an increasingly large share of healthcare costs.

A recent study showed patients with type 2 diabetes did better if given the combination therapy at the outset than if given 1 of the components as monotherapy.

California’s approach to the healthcare marketplace, Covered California, has successfully held down premium costs because it has authority to select health insurers.

A survey conducted by MaPS/Millward Brown Analytics, on behalf of Memorial Sloan Kettering Cancer Center, has identified multiple concerns of American consumers with cancer clinical trial participation, which could be responsible for the dismal 4% national enrollment rate in clinical trials.

What we're reading, May 24, 2016: Doubt grows about the stability of the Anthem-Cigna merger; use of e-cigarettes and vaping devices stalls in the US; and drugmakers are cautious about developing a Zika virus.

What we're reading, May 23, 2016: Oklahoma governor vetoes bill banning abortion; the FDA approved a new nutrition label highlighting sugar added; and 7 years after death panels, conversations on end-of-life planning are becoming more common.

One year after being hospitalized for heart failure, one-third of patients had not returned to work, according to a study presented at Heart Failure 2016 and the 3rd World Congress on Acute Heart Failure.

A phase 1 study in 225 patients diagnosed with breast cancer, non-small cell lung cancer, glioblastoma, melanoma, or colorectal cancer has concluded that abemaciclib, a selective inhibitor of the cell cycle regulators CDK4/6, has single-agent activity in specific tumor types.

For patients with private drug insurance plans, out-of-pocket expenses, not the timing of patient reimbursements, have a greater affect on medication adherence.

Finding diabetes and treating it early can prevent high healthcare costs in the long term, the authors day.

The updated label reflects research that shows how hard it is to consume key nutrients and maintain calorie limits in a diet overwhelmed by sugar. The label will be a legacy of First Lady Michelle Obama's focus on better nutrition to combat childhood obesity.

An Oklahoma-based non-profit hospital is the latest medical facility to sue pharmaceutical giant Genentech,accusing the company of shipping less than the labeled claim of the anticancer drug trastuzumab (Herceptin) in each multi-dose vial.

Only a small percentage of eligible employees used an online price transparency tool designed to help them understand healthcare spending. Furthermore, use of the tool was not associated with a decrease in spending.

US and European professional societies coordinated their announcement to reduce confusion for physicians and payers.

During 2010-2011, there were 506 annual antibiotic prescriptions per every 1000 population, but only 353 were likely appropriate, researchers found.

The top stories in managed care included the Supreme Court declining to rule on the contraception case Zubik v Burwell, Oklahoma and Louisiana both move toward expanding Medicaid, and the price of the opioid overdose drug naloxone has increased 17-fold over 2 years.

California ex-military who need mental health care either do not receive treatment or receive inadequate care, study finds.

Men and women diagnosed with colorectal cancer who were class I obese had the lowest risk of dying due to their cancer, according to a new study published in JAMA Oncology.

The sequence of events that led to Thursday's complaint points to a coordinated effort to challenge Myriad Genetics' long-held position that it does not share information on public databases.

Recent coverage of our peer-reviewed research, in the healthcare and mainstream press.

A microchip sensor that can measure specific volatile compounds in the breath of those with lung cancer, is being developed by research groups in the United States and in Britain.

Primary medication nonadherence is a widespread public health problem; however, the subject lacks standardized definitions and measures.

Value, cost, and the patient are taking center stage during the ISPOR 21st Annual International Meeting, which is being held May 21-25, 2016, in Washington, DC.

What we're reading, May 20, 2016: For the third time the FDA delayed a rule about generic drug labeling; 10 years ago a government report warned of a prison health crisis, but was blocked from publication; and Oklahoma lawmakers pass a bill making it a felony to perform an abortion.

One of the many great conveniences of urgent care clinics is that many have their own pharmacy, which eliminates the patient’s need to go to another location after a visit.

Right now, islet transplant therapy requires donated cells. The hope is that lab-grown islets could vastly expand the pool of patients who could get treatment.